AQST - Aquestive Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

AQST is currently covered by 5 analysts with an average price target of $10.35. This is a potential upside of $4.15 (66.94%) from yesterday's end of day stock price of $6.2.

Aquestive Therapeutics's activity chart (see below) currently has 89 price targets and 87 ratings on display. The stock rating distribution of AQST is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 17.99% with an average time for these price targets to be met of 81.63 days.

Highest price target for AQST is $10, Lowest price target is $7, average price target is $8.25.

Most recent stock forecast was given by FRANCOIS BRISEBOIS from OPPENHEIMER on 07-Sep-2025. First documented stock forecast 19-Aug-2018.

Currently out of the existing stock ratings of AQST, 13 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$8

$2.2 (37.93%)

$12

1 months 1 days ago
(07-Sep-2025)

0/3 (0%)

$2.99 (59.68%)

Buy

$10

$4.2 (72.41%)

$10

3 months 22 days ago
(16-Jun-2025)

8/30 (26.67%)

$6.65 (198.51%)

290

Buy

$7

$1.2 (20.69%)

$9

4 months 7 days ago
(01-Jun-2025)

5/7 (71.43%)

$4.19 (149.11%)

259

Buy

$8

$2.2 (37.93%)

$10

7 months 2 days ago
(06-Mar-2025)

1/8 (12.5%)

$5.35 (201.89%)

52

Buy

$9

$3.2 (55.17%)

$9

1 years 1 days ago
(07-Oct-2024)

0/10 (0%)

$4.08 (82.93%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AQST (Aquestive Therapeutics) average time for price targets to be met?

On average it took 81.63 days on average for the stock forecasts to be realized with a an average price target met ratio 17.99

Which analyst has the current highest performing score on AQST (Aquestive Therapeutics) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the current lower performing score on AQST (Aquestive Therapeutics) with a proven track record?

FRANCOIS BRISEBOIS

Which analyst has the most public recommendations on AQST (Aquestive Therapeutics)?

Raghuram Selvaraju has 3 price targets and 17 ratings on AQST

Which analyst is the currently most bullish on AQST (Aquestive Therapeutics)?

Raghuram Selvaraju with highest potential upside - $4.2

Which analyst is the currently most reserved on AQST (Aquestive Therapeutics)?

Randall Stanicky with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?